Neuropsychiatric manifestations of typhoid fever in 959 patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008581:Meningitis / Q000209:etiology; D001523:Mental Disorders / Q000209:etiology*; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology; D009207:Myoclonus / Q000209:etiology; D009422:Nervous System Diseases / Q000209:etiology*; D009443:Neuritis / Q000209:etiology; D009461:Neurologic Manifestations; D009549:Nigeria; D010300:Parkinson Disease / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D012559:Schizophrenia / Q000209:etiology; D012640:Seizures / Q000209:etiology; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014435:Typhoid Fever / Q000150:complications* / Q000188:drug therapy
D002701:Chloramphenicol; D014295:Trimethoprim; D013420:Sulfamethoxazole